JPMorgan Starts Evolent Health (EVH) at Overweight
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $4.17 --0%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Join SI Premium – FREE
JPMorgan initiated coverage on Evolent Health (NYSE: EVH) with an Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Evolent Health click here. For more ratings news on Evolent Health click here.
Shares of Evolent Health closed at $18.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- JPMorgan Downgrades TRONOX (TROX) to Underweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
